Medlab Clinical Limited announced the appointment of Mr. Kerem Kaya as Company Secretary of Medlab. Mr. Kaya joins Medlab with extensive pharmaceutical industry and financial experience gained at Novartis. Mr. Kaya has spent nearly 15 years at Novartis Pharmaceuticals working across several divisions, notably spending five years as Global Finance Projects Manager of Novartis AG where he helped develop financial efficiencies across the business globally. Mr. Kaya was most recently Head of Finance Planning and Analysis for the Australian and New Zealand operations.